Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
2.
Am J Drug Alcohol Abuse ; 49(6): 766-786, 2023 11 02.
Article in English | MEDLINE | ID: mdl-37921633

ABSTRACT

Background: One-third of people living with HIV (PLHIV) have alcohol misuse or alcohol use disorders which negatively affect course and outcome of HIV.Objectives: The meta-analysis sought to evaluate the effectiveness of brief interventions (BI) on alcohol and HIV outcomes in PLHIV with alcohol misuse.Methods: We included clinical trials published between 1990 and September 2022 on adults with harmful/hazardous alcohol use; only randomized clinical trials (RCTs) were included in the meta-analysis. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Clinical Trials.Gov, and the World Health Organization's International Clinical Trials Registry Platform databases. Cochrane's risk-of-bias assessment was used.Results: Eighteen studies were included in the narrative synthesis, and a meta-analysis could be performed on 13 studies. Among the included RCTs, seven showed a low risk and two showed a high risk of bias; others showed some concerns. There was no evidence of publication bias. Compared to the control, BI significantly reduces the drinks per drinking day (N = 5, Hedge's g= -0.45, 95%CI = -0.58, -0.32) and the number of heavy drinking days (N = 4, Hedge'sg = -0.81, 95% CI= -0.94, -0.67) between 3-6 months post-intervention. BI also reduces the odds of mortality by 42% (N = 7, OR = 0.58, 95% CI = 0.34, 0.99) in 6-12 months. BI does not change the alcohol risk scores and transition to harmful alcohol use; it does not improve adherence to Anti-Retroviral Therapy and increase viral suppression.Conclusion: Policymakers must introduce and scale up integrated screening and brief intervention services within HIV clinics and primary care.


Subject(s)
Alcoholism , HIV Infections , Adult , Humans , Alcoholism/complications , Alcoholism/therapy , Crisis Intervention , HIV Infections/complications , HIV Infections/therapy
3.
World J Psychiatry ; 13(8): 495-510, 2023 Aug 19.
Article in English | MEDLINE | ID: mdl-37701540

ABSTRACT

Rapid-cycling bipolar disorder (RCBD) is a phase of bipolar disorder defined by the presence of ≥ 4 mood episodes in a year. It is a common phenomenon characterized by greater severity, a predominance of depression, higher levels of disability, and poorer overall outcomes. It is resistant to treatment by conventional pharmacotherapy. The existing literature underlines the scarcity of evi-dence and the gaps in knowledge about the optimal treatment strategies for RCBD. However, most reviews have considered only pharmacological treatment options for RCBD. Given the treatment-refractory nature of RCBD, nonpharmacological interventions could augment medications but have not been adequately examined. This review carried out an updated and comprehensive search for evidence regarding the role of nonpharmacological therapies as adjuncts to medications in RCBD. We identified 83 reviews and meta-analyses concerning the treatment of RCBD. Additionally, we found 42 reports on adjunctive nonpharmacological treatments in RCBD. Most of the evidence favoured concomitant electroconvulsive therapy as an acute and maintenance treatment. There was pre-liminary evidence to suggest that chronotherapeutic treatments can provide better outcomes when combined with medications. The research on adjunctive psychotherapy was particularly scarce but suggested that psychoeducation, cognitive behavioural therapy, family interventions, and supportive psychotherapy may be helpful. The overall quality of evidence was poor and suffered from several methodological shortcomings. There is a need for more methodologically sound research in this area, although clinicians can use the existing evidence to select and individualize nonpharmacological treatment options for better management of RCBD. Patient summaries are included to highlight some of the issues concerning the implementation of adjunctive nonpharmacological treatments.

4.
J Addict Med ; 17(2): e78-e86, 2023.
Article in English | MEDLINE | ID: mdl-36001065

ABSTRACT

BACKGROUND AND AIMS: Multiple substance use is a common but underrecognized problem in patients on opioid agonist treatment (OAT). Co-occurring substance misuse is associated with poor clinical and psychosocial outcomes. We aimed ( a ) to determine the effect of screening and brief intervention (SBI) for substance misuse in people on OAT and (b) to qualitatively summarize the implementation of SBI. METHODS: We performed a systematic review of clinical trials on the efficacy of SBI for alcohol and drug misuse in participants on OAT. We searched 5 electronic databases and included published studies and unpublished trials. We measured the standardized mean difference in substance risk scores before and after intervention. We also estimated the standardized mean difference in alcohol consumption per day before and after intervention. RESULTS: We included a total of 8 studies; 5 of these were included in the meta-analysis, and all were reviewed for narrative synthesis. We observed a significant change in the pre-post brief intervention substance risk scores with a medium effect size (Hedges g = 0.752, 95% confidence interval, 0.405-1.099). Sensitivity analyses with different pretest-posttest correlations did not change our result. Modest effects of SBI were found in reducing both alcohol and illicit drug risk scores, and among the population on methadone and buprenorphine treatment. We also observed a significant decrease in alcohol consumption per day 3 months after SBI. Studies showed a limited and incomplete screening for substance misuse and delivery of brief intervention in OAT settings. CONCLUSIONS: Screening and brief intervention may be a potential treatment for co-occurring substance misuse among patients on OAT.


Subject(s)
Drug Users , Substance-Related Disorders , Humans , Crisis Intervention , Analgesics, Opioid/therapeutic use , Substance-Related Disorders/epidemiology , Substance-Related Disorders/therapy , Substance-Related Disorders/complications , Alcohol Drinking/prevention & control
5.
Natl J Maxillofac Surg ; 14(3): 444-449, 2023.
Article in English | MEDLINE | ID: mdl-38273908

ABSTRACT

Background: Smokeless and smoking tobacco use results in increased oxidative stress and lipid peroxidation, which play a major role in the causation of cancer in tobacco habituates. Malondialdehyde (MDA) is a product of lipid peroxidation, and glutathione peroxidase (GPx) and superoxide dismutase (SOD), the main enzymes in the antioxidant defense system, are assessed among tobacco users. This study gave insight into the relationship between tobacco use, oxidative stress, and antioxidant enzyme activity. Aims and Objectives: This study aimed to estimate the levels of lipid peroxidation product MDA and antioxidant enzymes SOD and GPx among tobacco users and compare them with controls. Method: A case-control study comprising 30 smokeless tobacco users, 30 smokers, and 30 controls was enrolled for the study. Serum MDA was assayed by the thiobarbituric acid method; serum SOD and GPx were assayed using Ransel antioxidant kits. The results were statistically analyzed using descriptive and inferential statistical analysis. Results: Serum MDA levels, which indicate oxidative stress, were increased among all tobacco users and significantly increased among smokeless tobacco users as compared to smokers. Serum SOD and GPx levels were decreased among both forms of tobacco users compared with controls. With an increase in duration and frequency of tobacco use, there was a significant increase in serum MDA levels among both smokers and chewers and a decrease in serum SOD and GPx levels. Conclusion: In the present day, the tobacco epidemic has attained enormous proportions with the tobacco habit starting as early as 13-14 years and leading to serious conditions with high morbidity and mortality. These biochemical parameters such as MDA, SOD, and GPx, which act as marker of oxidant and antioxidant system, can constitute important tools for evidence-based medicine for educating patients and motivating interventions in tobacco cessation therapy.

6.
Dent Res J (Isfahan) ; 19: 53, 2022.
Article in English | MEDLINE | ID: mdl-36159064

ABSTRACT

The corona virus malady 2019 (COVID-19) pandemic has rekindled the well established argument regarding the role of dental aerosol in transference of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). Aerosols and droplets are generated amid innumerable dental procedures. With the commencement of the COVID-19 pandemic droplet, a review of the infection/disease control strategies for aerosols is required. We do not know where this pandemic is directed. We do not have conclusive evidence for an optimal management strategy. Every day brings in varying information, so recognizing the hazard created by aerosols will help diminish the probability of infection transfer at the time of dental procedures. Hence, the author assessed the evidence-based medical and dental literature in relation to "aerosol' that documented the source of transmission of aerosol through various potential routes, addressed the risk potential to patients and the dental team, and assessed the additional measures that might minimize the viral transmission if regularly adopted. In this article, the author evaluated and compiled dental guidelines by various countries and various health-care associations in context to aerosol-generating procedures and has made recommendations for the restriction of dental aerosols and splatter in routine dental practice.

7.
Addiction ; 117(3): 545-558, 2022 03.
Article in English | MEDLINE | ID: mdl-34159673

ABSTRACT

BACKGROUND AND AIMS: Low and middle-income countries (LMIC) have a disproportionately higher alcohol-attributable disease burden, in conjunction with a minimal focus on primary prevention. Screening and brief interventions can be a promising approach to address this problem. This systematic review aimed to perform a qualitative and quantitative synthesis of studies of brief interventions for harmful and hazardous alcohol use in LMIC. METHODS: Systematic review of randomized controlled trials of brief interventions for harmful and hazardous alcohol identified from four electronic databases, conducted in any country identified as LMIC as per the World Bank. We measured differences in intervention and control groups on risk-scores using standard screening instruments, the frequency of heavy drinking, the drinking risk-level, or quality of life and other mental health-related outcomes. RESULTS: A total of 14 studies were included, seven of them from South Africa. On standardized screening instruments, the brief intervention (BI) group had significantly lower scores than controls at 3 months (Hedges' g = - 0.34, P = 0.04), but the effects did not persist at 6- and 12-month follow-up (g = - 0.06, P = 0.68 and g = 0.15, P = 0.41, respectively). There was little evidence to suggest that BIs led to changes in the frequency of heavy drinking or change in the risk level of alcohol use. Surprisingly, a single session (g = -0.55, P < 0.001) fared better than multiple sessions (g = -0.03, P = 0.85). A nurse delivered brief intervention (g = -0.44, P = 0.02) showed better results than BIs delivered by others (g = -0.14, P = 0.66), whereas the outcomes were similar for young adults and middle-age people. CONCLUSION: Brief interventions for alcohol use show some promise in low- and middle-income countries. Specifically, a single session, nurse-delivered brief intervention for harmful and hazardous alcohol use appears to show a small but significant positive effect in low- and middle-income countries.


Subject(s)
Alcohol-Related Disorders , Alcoholism , Alcohol Drinking/prevention & control , Alcoholism/diagnosis , Alcoholism/therapy , Crisis Intervention , Developing Countries , Ethanol , Humans , Mass Screening , Middle Aged , Quality of Life , Young Adult
8.
Natl J Maxillofac Surg ; 12(1): 13-16, 2021.
Article in English | MEDLINE | ID: mdl-34188395

ABSTRACT

AIM: The aim of this study was to assess the marginal bone level changes at dental implants after 1 year in function. METHODS: Detailed searches from PubMed databases were made. A MEDLINE search (PubMed) published in the English language from 1980 to December 2018 was included in this study. RESULTS: The electronic database research (MEDLINE) produced 166 corresponding articles. One hundred and twenty studies were excluded on the basis of abstract while the 46 researches were used chosen for full-text examination after the title and abstract testing, and 41 studies were excluded that did not meet the requirements of our inclusion and exclusion criteria. A total of 5 studies for a quantitative analysis were taken into account. CONCLUSION: Within the limits of the study, the mean marginal bone loss (MBL) was found to be 0.56 mm. A statistically significant difference in the MBL was found between the various studies.

11.
Natl J Maxillofac Surg ; 7(1): 17-20, 2016.
Article in English | MEDLINE | ID: mdl-28163473

ABSTRACT

The purpose of this review is to give a brief background to enable the judicious use of widely performed serum cancer markers. The markers could be product of cancerous cell or as response to cancer. They are usually proteins, which are mainly found in blood or urine. These markers may be employed to predict primary or secondary tumor risk. Sometimes, non-cancerous conditions can also cause elevation of some tumor markers to be higher than normal. Besides, not every cancer patient may have raised level of a tumor marker. For these reasons, knowledge about cancer biomarkers has increased tremendously. Awareness for cancer and related tumor markers providing great opportunities for improving the management of cancer patients by enhancing the efficiency of detection and efficacy of treatment.

12.
Natl J Maxillofac Surg ; 7(1): 29-32, 2016.
Article in English | MEDLINE | ID: mdl-28163475

ABSTRACT

OBJECTIVE: The objective of this study was to assess the effectiveness of different types of fixation in the enhancement of posttraumatic inferior alveolar nerve (IAN) recovery in displaced mandibular angle fracture and to establish. PATIENTS AND METHODS: Thirty patients of displaced mandibular angle fracture were treated with preangulated plate and three-dimensional (3D) matrix plate in two groups and were observed during follow-up at 04,06 and 12 weeks along with other parameters. RESULTS: Fifteen patients were treated with preangulated plate and 15 patients with 3D matrix miniplate. There was early nerve recovery in Group A than Group B, with residual paresthesia 20% in Group A and 26.6% in Group B at the end of 12-week follow-up. CONCLUSION: The displaced mandibular angle fracture with posttraumatic IAN paresthesia treated with preangulated plate has shown evidence of early nerve recovery than those fractures were treated with matrix miniplate. The fracture fragments displaced more than 9 mm have shown poor nerve recovery in both groups.

SELECTION OF CITATIONS
SEARCH DETAIL
...